(Q44635862)

4 December 2017

title

K-ras mutation in tamoxifen-related endometrial polyps (English)

1 reference

4 December 2017

K‐ras mutation in tamoxifen‐related endometrial polyps (English)

1 reference

26 March 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584071

26 March 2024

1 reference

26 March 2024

5

Makoto Emoto

1 reference

4 December 2017

Tatsuhiko Kawarabayashi

6

object named as

Tatsuhiko Kawarabayashi

1 reference

4 December 2017

1

Toru Hachisuga

1 reference

4 December 2017

Takashi Miyakawa

2

1 reference

4 December 2017

Hiroshi Tsujioka

3

1 reference

4 December 2017

Shinji Horiuchi

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11728

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11728

26 March 2024

1 reference

26 March 2024

1 reference

4 December 2017

volume

98

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1890-1897

1 reference

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Alterations in steroid hormone receptors in the tamoxifen-treated endometrium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Pathology of endometrium treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

K-ras mutations in endometrial carcinomas with microsatellite instability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by alpha-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11728

7 January 2021

Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats

32

1 reference

26 March 2024

Identifiers

DOI

10.1002/CNCR.11728

1 reference

4 December 2017

1 reference